Multi purpose perfusion cannula

Abstract: A cannula is provided particularly for use in connection with aortic perfusion. In its simplest form, it comprises a perfusion cannula with a main channel which is fluidly connected at one end to an intra-aortic portion of the cannula and, at the other end, is fluidly connected to the aortic perfusion line of a cardiopulmonary bypass. A first side port is adapted for fluid connection to an extra-aortic pump or to an intra-aortic balloon pump. The other end of the first port is in fluid connection with the intra-aortic portion of the cannula. This arrangement permits the insertion of the intra-aortic balloon pump through the first port, into the intra-aortic portion of the cannula, and beyond into the descending aorta. A blood pressure port is fluidly connected to a blood pressure monitoring tube said tube is located within the intra-aortic portion and extends therein to a pressure point upstream of the distal end of the portion. The other end of the tube is adapted for connection to a blood pressure measuring or monitoring device.

Description: The present invention is directed to an improved perfusion cannula, more particularly one for use in the aorta during open heart surgery. BACKGROUND OF THE INVENTION The nature of the population for open heart surgery is rapidly changing; in recent years, an increasing number of high risk patients are being brought to the operating table for this procedure. There are a number of reasons for this. In general, such patients are substantially older than before. Specifically, the mean age is approximately seventy-one years while, only twelve years ago, the mean age was only fifty-one years. In essence, the problems arise as a result of the success of other treatments. Improvements in medical treatment have resulted in the availability of a wide range of cardiac drugs which will prevent angina, thereby permitting patients to survive longer, even though heart problems are present. In addition, angioplasty and arterectomy of single, double, and even multiple vessels are commonplace; thus, many patients come to surgery only after several other cardiac procedures have been carried out. In addition, the percentage of second operations performed on the same patient is also increasing. In some areas, it is as high as 10% to 30%; this is because patients are surviving longer after the first operation. Thus, patients seeking open heart surgery are much sicker and frailer than they ever were. They present higher risks and, of course, increased anxiety on the part of both the patient and the surgeon. Hence, the use of such expedients as the intra-aortic balloon has been rising steadily. This device is used to assist, on a temporary basis, the failing heart after surgery is completed. In almost every case of coronary artery bypass surgery, the internal mammary artery (IMA) is used. This artery tends to become narrower when the blood pressure falls just after all the grafts have been anastomosed and the aortic cross pump removed. This phenomenon is called arterial spasm. This is extremely detrimental to the patient since it does not permit good perfusion of the left heart, thus reducing blood pressure even further. The fact that the IMA is usually implanted in the left anterior descending artery of the heart is a contributing factor. A vicious cycle is created and must be treated immediately by insertion of an Intra-Aortic Balloon Pump (IABP), drugs, or even the insertion of an additional graft, taken from the saphenous vein, into the left anterior descending artery. If treatment is not carried out promptly, the patient may die. A further problem resides in the age of the patients and the condition of their arteries. It is common to find diffuse atherosclerosis in such patients, as well as aortas which are seeded with calcified plaque. Thus, the risk of stroke is substantially increased because, if a small piece of calcium is dislodged, it can easily be carried to the brain as an embolism through, for example, the brachiocephalic artery. This can occur as a direct result of certain mechanisms; specifically, cross clamping of the ascending aorta to isolate and cool the heart for the surgery. Another cause is the jet of blood exiting from the aortic cannula which can, if it impinges on the walls of the aorta, dislodge plaque therefrom, especially in the region of the aortic arch. Moreover, this area generally has greater calcium deposits than any other part of the aorta. Many of the patients suffer from peripheral atherosclerosis, wherein the femoral arteries are extremely narrowed or even fully occluded. This condition makes the introduction of the IABP through that artery virtually impossible or, at best, at high risk with a strong likelihood of complications. There also are occasions when heart failure occurs under conditions such that the IABP and drugs are insufficient to maintain the patient. In such situations, an extra-aortic pump (EAP), particularly one which will be activated and controlled by the existing IABP console, can be effective. While the IABP can increase coronary blood flow by 5% to 15% the EAP can increase the flow by 100% or more. Still another problem relates to the perioperative monitoring of the patient's blood pressure. This can be extremely difficult, and sometimes even impossible, the use of either the radial or femoral artery. In US-A 4,287,892 a cannula assembly for intra-aortic balloon devices is described. Said cannula contains a balloon catheter adapter to permit proper positioning of the intra-aortic balloon within the aortic arch. This patent is completely silent how this cannula can be used in combination with a extra-aortic pump. In EP 0 286 756 A1 vascular cannulae for transfemoral cardiopulmonary bypass are disclosed. The cannulae are used remote from the heart. SUMMARY OF THE INVENTION It is among the objects of the present invention to provide a means whereby an intra-aortic balloon, in conjunction with a IABP console, can be used to assist the failing heart, especially during open heart surgery, thereby preventing many possible complications. The IABP can be used for such high risk patients as those suffering from (1) severe left main coronary artery disease, (2) failed angioplasty, (3) failed arterectomy, (4) low ejection fraction, (5) intractable angina, (6) severe triple vessel coronary disease, (7) repeat coronary artery bypass grafting, (8) prevention of IMA spasm, (9) post-operative crisis, (10) temporary post-operative low output syndrome, and (11) in any situation in which introduction of the balloon through the femoral arteries is inadvisable or impossible. There are also situations wherein the intra-aortic balloon pump is insufficient to sustain the patient. Therefore, the present invention provides a means whereby an extra-aortic pump can be quickly connected directly to the cannula for immediate operation. Moreover, the extra-aortic pump can also be used to convert a cardiopulmonary bypass to a pulsatile bypass, thus minimizing the onset of complications which result from non-pulsatile bypasses. The pump can be used in severe post-operative heart failure and, if the patient is temporarily dependent on the pump, the device can be inserted directly through the ascending aorta after the cannula has been removed. The present invention also permits monitoring blood pressure deep inside the aorta. This can be done while the IABP or extra-aortic pump is operational, as well as while the patient is on the cardiopulmonary bypass. It is further among the objects of the present invention to provide a cannula which is designed to prevent or minimize dislodgment of calcium particles in aortas which are severely calcified. The cannula of the present invention may be provided with an inflatable balloon which acts to occlude the aorta adjacent the heart. This isolates the latter and obviates the need for cross clamping. Cross clamping and dislodgment of debris by the cannula are the two main reasons for the formation of calcium embolisms, a major cause of stroke. The device eliminates the need to cool the patient to extreme low temperatures, nor is it necessary to perform the operation with complete circulatory arrest. The latter, in particular, carries a very high morbidity. The present invention provides a cannula which, while it will be described in connection with aortic perfusion, is capable of uses elsewhere as well. According to claim 1, it comprises a perfusion cannula for insertion into an artery specifically for use in the aorta during open heart surgery, said perfusion cannula comprising an intra-aortic portion and a main channel connected to the intra-aortic portion of the cannula, said main channel being adapted for connection to an aortic perfusion line of a cardiopulmonary bypass, said intra-aortic portion having a proximal end connected to said main channel and a distal end remote from said main channel, said main channel having a first port, and a second port; characterised by a blood pressure monitoring tube, said second port being connected to the blood pressure monitoring tube, said tube being within said intra-aortic portion and extending to a pressure point upstream of said distal end, said tube being adapted for connection to a blood pressure monitoring device. The cannula is inserted in the aortic arch and, in the primary embodiment of the invention, extends a relatively short distance longitudinally of the aorta. Advantageously, in this form of the cannula, the portion may terminate approximately opposite the brachiocephalic artery. The end of the first port remote from the portion may have a plug located therein. Within the plug is a one-way valve which prevents outward flow of blood, but permits insertion of the intra-aortic balloon. The balloon is controlled by a console which electronically monitors the heart beat and expands and contracts the balloon in synchronism therewith. Since the extra-aortic pump displaces a much greater volume than does the IABP, because it is close to the coronary arteries, it is necessary to remove the plug (along with the valve) before attaching the extra-aortic pump to the cannula. In another embodiment of the invention, an inflatable occlusive balloon surrounds at least part of the intra-aortic portion of the cannula. In this modification, the first port is also fluidly connected to the occlusive balloon and adapted for connection to an intra-aortic balloon pump, as well as to a control device therefor. The IABP console can operate the extra-aortic pump, as well. In a third form of the device, the occlusive balloon is provided as previously described. In addition thereto, an inflatable non-occlusive balloon surrounds the intra-aortic portion at or adjacent the distal end thereof. The portion is longer than in the first two embodiments and the distal end is located in the descending aorta. The non-occlusive balloon serves two purposes. First, it acts as a guide to lead the intra-aortic portion around the curve of the aortic arch into the descending aorta. It minimizes the contact between the distal end of the portion and the anterior wall of the aorta. In this way, the likelihood of dislodgment of a calcium particle is reduced. Second, since the main channel and the intra-aortic portion constitute or contain a blood passage, the presence of the non-occlusive balloon centers the exit of the blood passage so that the stream of perfused blood coming from the cardiopulmonary bypass is substantially parallel to the walls of the descending aorta. As a result, impingement of the stream on the walls is kept to a minimum. This, too, substantially reduces the risk of calcium particles being dislodged. When a cannula is inserted into an artery, particularly the aorta, there is always the danger of the introduction of an air bubble. Should this be carried to the brain, a stroke could result. It is, therefore, of primary importance that this be prevented. To assist in doing so, there is provided a trocar which is flexible and moves axially within the cannula itself. The trocar is hollow and contains a guide wire by which the surgeon is able to manipulate it and minimize or avoid damage to the artery walls. The trocar terminates, at its inner end, in a head which comes to a point. After the surgeon has made the initial incision in the artery, the point of the trocar is inserted to dilate the opening. To facilitate the elimination of air, the head contains holes, preferably one at each of the upper and lower surfaces of the head and one at the point, to allow air and blood to pass through the head to the rear portion of the trocar. The air, along with some blood, is permitted to leak out of the cannula due to the imperfect fit between the guide wire and the plug at the outer end. When the trocar is almost completely withdrawn, the cannula is clamped to prevent any further loss. Thereafter, the trocar is completely removed and the cannula is connected to the perfusion line of a cardiopulmonary bypass. This eliminates or minimizes the risk of an air bubble getting to the brain of the patient. Moreover, it also minimizes blood loss. BRIEF DESCRIPTION OF THE DRAWINGS In the accompanying drawings, constituting a part hereof, and in which like reference characters indicate like parts, Figure 1 is a schematic view, partly in section, of the first embodiment of the present device with the intra-aortic portion located in the aorta; Figure 2 is a view similar to that of Figure 1 showing the second embodiment of the invention with the occlusive balloon and an intra-aortic balloon positioned in the aorta; Figure 3 is a view similar to that of Figure 1 of the third embodiment of the invention, without the aorta, but with both the occlusive balloon and the non-occlusive balloon in place; Figure 4 is a view similar to that of Figure 1 of the embodiment of Figure 3 with an intra-aortic balloon in the descending aorta; Figure 5 is a schematic sectional view of the non-occlusive balloon; Figure 6 is a schematic view, partly in section, of the cannula of the present invention with a trocar within. DETAILED DESCRIPTION OF THE INVENTION Referring particularly to Figure 1, cannula 1 comprises main channel 2, intra-aortic portion 11, first side port 3, and blood pressure port 5. Main channel 2 is connected to the aortic perfusion line of a cardiopulmonary bypass (not shown) and carries the perfused blood into intra-aortic portion 11. First port 3 is connected to extra-aortic pump 38 which includes diaphragm 39. The pump alternately pumps blood in and withdraws it and is controlled by console 41. Blood pressure port 5 receives blood pressure tube 46 which extends within cannula 1 to opening 44 adjacent the distal end of intra-aortic portion 11. When opening 44 is located in this manner, the blood pressure reading is not influenced by the flow of blood exiting intra-aortic portion 11. The other end of tube 46 is connected to blood pressure monitor 40. For the assistance of the surgeon, locator ring 8 is placed on cannula 1 so that the proper depth of insertion can easily be accomplished. The aorta comprises ascending aorta 16, aortic arch 17, and descending aorta 18 (not shown in Figure 1). Preferably, cannula 1 is inserted into ascending aorta 16 or aortic arch 17, but upstream of brachiocephalic artery 31. Another embodiment of the invention is shown in Figure 2. Cannula 1 comprises main channel 2, intra-aortic portion 11, first side port 3, and blood pressure port 5, all substantially as described with respect to Figure 1. However, there is provided occlusive balloon 13 which completely blocks ascending aorta 16. This enables heart 9 and aortic valve 10 to be isolated while the surgery is performed. Second side port 6 is provided to introduce and withdraw fluid into and out of occlusive balloon 13. If the blend is air, it increases the risk to the patient, as an air bubble could be formed should balloon 13 rupture. Therefore, it is preferable that a liquid such as saline be used for this purpose. Fluid tube 4 carries the fluid which is used to inflate and deflate balloon 15. This form of the device can be used with intra-aortic balloon 15. This is part of a intra-aortic balloon pump wherein fluid is introduced into and withdrawn from balloon 15 as indicated by arrow 45. The action of the pump is controlled by console 41 (see Figure 1). Balloon 15 is inserted past brachiocephalic artery 31, carotid artery 32, and subclavian artery 33 into descending aorta 18. In Figure 3, still another form of the device is shown, but without particular reference to the aorta in which it may be placed. Cannula 1 is similar to the embodiment shown in Figure 2, but the intra-aortic balloon is not present. Most of the elements correspond with the device of Figure 2 and need not be further described here. It should be noted that intra-aortic portion 11 is substantially longer than its corresponding part in the embodiment shown in Figure 2. Moreover, non-occlusive balloon 14 is provided adjacent its distal end. Second side port 6 is connected to fluid tube 23 which feeds fluid to - and withdraws it from - balloon 14. First side port 3 is provided with plug 35 containing one-way valve 36. Valve 36 prevents blood from flowing out of port 3, but permits the insertion of an intra-aortic balloon pump therethrough, if needed. Port 3 can also receive an extra-aortic pump, but it is necessary to remove plug 35 before the insertion thereof. This is important because the volume of blood pumped by the extra-aortic pump is much larger than that pumped by the intra-aortic balloon pump. In Figure 4, the foregoing embodiment is shown in the aorta along with intra-aortic balloon 15. Third side port 34 is connected to fluid tube 47 which carries fluid to and from balloon 14. A cross-section of balloon 14 is shown in Figure 5. Balloon 14 is provided with lobes 37 and surrounds portion 11. Balloon 14 performs two functions. On insertion of cannula 1 into the aorta, it gently guides portion 11 around the aortic arch past arteries 31, 32, and 33. As a result, the pressure and stress on the anterior wall of the aorta are minimized and the risk of dislodgment of calcium plaque, which is frequently found at that point, is reduced. In addition to the foregoing, balloon 14 centers the distal end of portion 11 and blood passage 42. Thus, when the perfused blood exits blood passage 42, the stream thereof is substantially parallel to the walls of the descending aorta, it does not impinge to any degree upon those walls and, therefore, the chance of plaque being dislodged is substantially and materially reduced. Referring now to Figure 6, there is provided hollow trocar 48, having head 49 and point 51. Holes 50 are in head 49 to allow the passage of blood therethrough and guide wire 52 is located within trocar 48. Air and blood pass through holes 50 into the rear portion of trocar 48 and leak out between wire 52 and plug 35. After all the air has been discharged, cannula 1 is clamped when trocar 48 is almost withdrawn. Plug 35 is removed and cannula 1 is connected to the perfusion line of a cardiopulmonary bypass. Thereafter, the clamp is released so that the perfused blood can circulate within the patient. While only a limited number of specific embodiments of the present invention have been expressly disclosed, it is, nonetheless, to be broadly construed and not to be limited except by the character of the claims appended hereto.

Claims: A perfusion cannula for insertion into an artery specifically for use in the aorta during open heart surgery, said perfusion cannula (1) comprising an intra-aortic portion (11) and a main channel (2) connected to the intra-aortic portion (11) of the cannula (1), said main channel (2) being adapted for connection to an aortic perfusion line of a cardiopulmonary bypass, said intra-aortic portion (11) having a proximal end connected to said main channel (2) and a distal end remote from said main channel (2), said main channel (2) having a first port (3), and a second port (5); characterised by a blood pressure monitoring tube (46), said second port (5) being connected to the blood pressure monitoring tube (46), said tube (46) being within said intra-aortic portion (11) and extending to a pressure point upstream of said distal end, said tube (46) being adapted for connection to a blood pressure monitoring device (40). A perfusion cannula as claimed in claim 1 comprising a locator ring (8) on said cannula (1) surrounding said cannula (1) and indicating proper location of said cannula (1) in said artery. A perfusion cannula as claimed in claim 1 wherein said pressure point is adjacent said distal end of said intra-aortic portion (11). A perfusion cannula as claimed in claim 1 comprising an inflatable occlusive balloon (13) surrounding at least a part of said intra-aortic portion (11), first port (3) being connected to said inflatable occlusive balloon (13) and being adapted for connection to an extra-aortic (38) or an intra-aortic (15) pump and to a control device (41) for said pump. A perfusion cannula as claimed in claim 1 wherein said artery comprises an ascending aorta (16), a descending aorta (18) and an aortic arch (17) therebetween and a non-occlusive balloon (14) surrounds said intra-aortic portion (11) at or adjacent said distal end and in said descending aorta (18), said non-occlusive balloon (14) being adjacent said proximal end. A perfusion cannula as claimed in claim 5 wherein said non-occlusive balloon (14) is soft. A perfusion cannula as claimed in claim 1 comprising a plug (35) in said first port (3) at an end remote from said near end, said plug (35) having a one-way valve (36) therein. A perfusion cannula as claimed in claim 7 wherein said valve (36) is adapted for entry of an intra-aortic balloon catheter (4) therethrough. A perfusion cannula as claimed in claim 1 comprising a hollow flexible trocar-tube (48) within said cannula (1), a flexible guide wire (52) in said tube, a head (49) at an inner end of said trocar (48), said head (49) ending in a point adapted for insertion into an artery during use of said cannula (1), said head having at least one hole (50) to allow blood and/or air to flow therethrough towards an outer end of said cannula (1) between said wire (52) and said plug (35), whereby air is removed from said artery.

Inventors: GABBAY SHLOMO, GABBAY, SHLOMO
Applicants: GABBAY SHLOMO, GABBAY, SHLOMO
Application year: 1993
Main classification: A61M1
IPC codes: A61M25, A61M1